1. Kazimirko V.K., Kovalenko V.N., Flegontova V.V. (2011) Involyucionnyj osteoartroz i osteoporoz. Doneck: Izdatel’ Zaslavskij A. Yu., 724 p. (in Russian)
2. Denisov-Nikol’skij Yu.I., Mironov S.P., Omel’yanenko N.P., Matvejchuk I.V. (2005) Aktual’nye problemy teoreticheskoj i klinicheskoj osteoartrologii. M., OAO “Tipografiya “Novosti”, 336 p. (in Russian)
3. Alekseeva L.I. (2019) Obnovlenie klinicheskih rekomendacij po lecheniyu bol’nyh osteoartritom 2019 goda. RMZH, no 4, pp. 2–6.
4. Souich P. (2014) Absorption, distribution and mechanism of action of SYSADOAS. Pharmacol Ther., vol. 142(3), pp. 362–74. doi: 10.1016/j. pharmthera.2014.01.002.
5. Monfort J., Pelletier J-P., Garcia-Giralt N., Martel-Pelletier J. (2007) Biochemical basis of the effect of chondroitin sulfate on osteoarthritis articular tissues. Ann Rheum Dis., no 75, pp. 285–289.